Passive immunization and its rebirth in the era of the COVID-19 pandemic

The COVID-19 pandemic, caused by SARS-CoV-2, has led to a rapid search for therapeutic and preventive measures because of the potentially severe course of infection. The antiviral drug, remdesivir, and the anti-inflammatory agent, dexamethasone, have shown beneficial effects. As the current COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavia, Charles S., Wormser, Gary P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834679/
https://www.ncbi.nlm.nih.gov/pubmed/33400975
http://dx.doi.org/10.1016/j.ijantimicag.2020.106275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834679/
https://www.ncbi.nlm.nih.gov/pubmed/33400975
http://dx.doi.org/10.1016/j.ijantimicag.2020.106275

Ejemplares similares